<jats:p>Systemic treatment of diabetic rats with a novel human growth factor, vascular endothelial growth factor (VEGF)-A165b, reversed neuropathic pain and peripheral nerve damage.</jats:p>
Journal article
Clinical Science
Portland Press Ltd.
01/10/2015
129
741 - 756